http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16cd90242d8e51c83d7a6d8a7bd9b87f
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Hughes H. Hughes |
| name | Stephen H Hughes Stephen H. Hughes |
| given-name | Stephen Stephen H. Stephen H |
| organization-name | Laboratory of Medicinal Chemistry, Center for Cancer Research, NCI−Frederick, NIH, Frederick, Maryland 21702; Laboratory for the Structure of Matter, Naval Research Laboratory, Washington, D.C. 20375; Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes, Digestive and Kidney Diseases, NIH, Bethesda, Maryland 20892, Katholieke Universiteit Leuven, Rega Institute, Minderbroedersstraat 10, B-3000 Leuven, Belgium; Experimental Retrovirology Section, Center for... HIV Drug Resistance Program, National Cancer Institute-Frederick, National Institutes of Health, Frederick, Maryland 21702, United States HIV Dynamics and Replication Program, National Cancer Institute , Frederick, Maryland, USA HIV Drug Resistance Program, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201,1 and Bionetics Research, Inc., NCI-Frederick Cancer Research Facility, P.O. Box B, Frederick, Maryland 21701-1013 HIV Drug Resistance Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States HIV Drug Resistance Program, National Cancer Institute, Frederick, MD 21702 Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA. HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, USA HIV Drug Resistance Program, National Cancer Institute at Frederick, Frederick, Maryland HIV Dynamics and Replication Program, National Cancer Institute-Frederick, National Institutes of Health, Frederick, MD; HIV Drug Resistance Program, National Cancer Institute at Frederick HIV Drug Resistance Program, National Cancer Institute, Frederick, MD 21702; ABL-Basic Research Program1 and National Cancer InstituteFrederick, Frederick, Maryland 21702, Department of Chemistry, McDaniel College, Westminster, Maryland 21157, Department of Chemistry, Yale University, New Haven Connecticut 06520, and Center for Advanced Biotechnology and Medicine (CABM) and Department of Chemistry, Rutgers University, Piscataway, New Jersey 08854 HIV Dynamics and Replication Program, CCR, National Cancer Institute, Frederick, Maryland, USA. ABL Basic Research Program, National Cancer Institute Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201,1 and Laboratory of Medicinal Chemistry, Center for Cancer Research, NCI-Frederick, NIH, Frederick, Maryland 21702, HIV Drug Resistance Program, Center for Cancer Research, NCI-Frederick, NIH, Frederick, Maryland 21702, Experimental Retrovirology Section, Center for Cancer Research, NCI, NIH, Bethesda, Maryland 20892, NMR Group, Laboratory of Proteomics and Analytical Technologies, SAIC Frederick, Frederick, Maryland 21702, Laboratory for the Structure of Matter, Naval Research Laboratory, Washington, D.C.... HIV Drug Resistance Program, Center for Cancer Research, National Cancer Institute at Frederick, 1050 Boyles St., Building 539 Rm. 130A, Frederick, MD 21702 HIV Drug Resistance Program, National Cancer Institute, National Institutes of Health, Frederick, MD 21702. Vector Design and Replication Section, and HIV Drug Resistance Program, National Cancer Institute at Frederick, P.O. Box B, Frederick, Maryland 21702-1201 HIV Drug Resistance Program, NCI-Frederick, Frederick, Maryland 21702 ABL-Basic Research Program, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201 Center for Advanced Biotechnology and Medicine and Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, New Jersey 08854, Center for Molecular Design, Janssen Pharmaceutica NV, Vosselaar, Belgium, Janssen Research Foundation, Spring House, Pennsylvania, Tibotec, 2800 Mechelen, Belgium, and HIV Drug Resistance Program, NIH National Cancer InstituteFrederick, Frederick, Maryland 21702 ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, Maryland 217024 ABL-Basic Research Program, Frederick Cancer Research and Development Center, National Cancer Institute, Frederick, Maryland 21702-1201 ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, Maryland 21702 HIV Drug Resistance Program, NCI-Frederick, Building 539, Frederick, Maryland 21702-1201 Center for Advanced Biotechnology and Medicine (CABM) and Rutgers University Chemistry Department, 679 Hoes Lane, Piscataway, NJ 08854-5638; and Advanced BioScience Laboratories–Basic Research Program, National Cancer Institute–Frederick Cancer Research and Development Center, P.O. Box B, Frederick, MD 21702-1201 HIV Drug Resistance Program1 and HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland HIV Drug Resistance Program, National Cancer Institute at Frederick, P.O. Box B, Building 539, Room 130A, Frederick, Maryland 21702-1201 HIV Drug Resistance Program, NCI-Frederick, PO Box B 539/130, Frederick, Maryland 21702 Gene Regulation and Chromosome Biology Laboratory and Molecular Biology of Carcinogenesis Laboratory, National Cancer Institute–Frederick Cancer Research and Development Center, ABL–Basic Research Program, Frederick, MD 21702-1201 Molecular Aspects of Drug Design Section and Gene Expression in Eukaryotes Section, ABL-Basic Research and Development Program, National Cancer Institute-Frederick Cancer Research and Development Center, P.O. Box B, Frederick, Maryland 21702, and Southern Research Institute-Frederick Research Center, 431 Aviation Way, Frederick, Maryland 21701 HIV-Drug Resistance Program, NCI-Frederick, Frederick, Maryland 21702-1201 BRI-Basic Research Program, National Cancer Institute-Frederick Cancer Research Facility, P.O. Box B, Frederick, Maryland 21701-1013 ABL-Basic Research Program, National Cancer Institute—Frederick Research and Development Center, Frederick, Maryland 21702-1201 National Cancer Institute, P.O. Box B, Frederick, MD 21702 HIV Drug Resistance Program Center for Cancer Research National Cancer Institute National Institutes of Health PO Box B Frederick MD 21702 USA HIV Drug Resistance Program, National Cancer Institute-Frederick, Frederick, Maryland, USA HIV Drug Resistance Program, Center for Cancer Research, National Cancer Institute-Frederick HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland 21702-1201 HIV Drug Resistance Program HIV Dynamics and Replication Program, National Cancer Institute, National Institutes of Health, Frederick, Maryland, USA ABL-Basic Research Program, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702 HIV Drug Resistance Program, National Cancer Institute−Frederick, Frederick, Maryland 21702 HIV Drug Resistance Program, National Cancer Institute, P.O. Box B, Frederick, MD 21702-1201; and Center for Advanced Biotechnology and Medicine and Department of Chemistry, Rutgers University, 679 Hoes Lane, Piscataway, NJ 08854-5638 MediChem Research, Inc., 12305 South New Avenue, Lemont, Illinois 60439, Program for Collaborative Research in the Pharmaceutical Sciences, Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, and ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, Maryland 21702 HIV Drug Resistance Program, National Cancer Institute—Frederick, National Institutes of Health, Frederick, Maryland, USA HIV-Drug Resistance Program, NCI-Frederick, Frederick, Maryland 21701 ABL-Basic Research Program, NCI Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201 Center for Molecular Design, Janssen Pharmaceutica, B-2350 Vosselaar, Belgium; Center for Advanced Biotechnology and Medicine, and Department of Chemistry, and Chemical Biology, Rutgers University, Piscataway, New Jersey 08854; Medicinal Chemistry, Johnson & Johnson Pharmaceutical Research & Development, Janssen-Cilag France, F-27106 Val de Reuil Cedex, France; Drug Discovery, Johnson & Johnson Pharmaceutical Research & Development, Spring House, Pennsylvania 19477; Tibotec, B-2800 Mechelen, Belgium;... Laboratory of Medicinal Chemistry and HIV Drug Resistance Program, Center for Cancer Research, National Cancer Institute−Frederick, National Institutes of Health, Frederick, Maryland 21702 and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 HIV Drug Resistance Program, National Cancer Institute at Frederick, Frederick, Maryland 21702-1201 Department of Biology, University of Utah, Salt Lake City, Utah 84112 Molecular Aspects of Drug Design Section and Retroviral Replication Laboratory, National Cancer InstituteFrederick, P.O. Box B, Frederick, Maryland 21702, McDaniel College, Westminster, Maryland 21157, Southern Research InstituteFrederick Research Center, 431 Aviation Way, Frederick, Maryland 21701, and Center for Advanced Biotechnology and Medicine and Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, New Jersey 08854 ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201 HIV Drug Resistance Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702 HIV Drug Resistance Program, National Cancer Institute-Frederick, National Institutes of Health, Frederick, Maryland, USA Advanced BioScience Laboratories-Basic Research Program, National Cancer Institute-Frederick Cancer Research and Development Center, P.O. Box B, Frederick, MD 21702-1201; and Center for Advanced Biotechnology and Medicine and Rutgers University Chemistry Department, 679 Hoes Lane, Piscataway, NJ 08854-5638 HIV-Drug Resistance Program National Cancer Institute-Frederick Cancer Research Facility, BRI-Basic Research Program, P.O. Box B, Frederick, Maryland 21701 HIV Drug Resistance Program, National Cancer Institute-Frederick, Frederick, Maryland 21702-1201, USA. hughes@ncifcrf.gov National Cancer Institute, Frederick, MD 21702 HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702; HIV-Drug Resistance Program, National Cancer Research Institute-Frederick, Frederick, Maryland 21702 HIV Dynamics and Replication Program, National Cancer Institute—Frederick, National Institutes of Health, Frederick, Maryland, USA Center for Advanced Biotechnology and Medicine (CABM) and Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, New Jersey 08854; HIV Drug Resistance Program, NCI-Frederick Cancer Research and Development Center, Building 539, Frederick, Maryland 21702; Laboratoire de Pharmacochimie, Section de Recherche, UMR 176 CNRS-Institut Curie, Batiment 110, Centre Universitaire, 91405 Orsay, France; Medicinal Chemistry Department, Johnson & Johnson Pharmaceutical Research and Development,... HIV Drug Resistance Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA ABL-Basic Research Program, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201,1 and Advanced BioScience Laboratories, Inc., National Cancer Institute—Frederick Cancer Research and Development Center, P.O. Box B, Frederick, Maryland 21701 ABL-Basic Research Program1 and; HIV Drug Resistance Program,3 National Cancer Institute—Frederick, Frederick, Maryland 21702-1201, and Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724 |
Incoming Links
Total number of triples: 334.